differences in glp 1 drugs GLP-1 receptor agonists New oral GLP-1 drug delivers

GLP-1 medications have the potential to disrupt multiple points in that cycle simultaneously. And thats not all Research has established the protective effects of GLP-1 for the heart but we recently showed that the cardioprotective effects of GLP-1 drugs in patients at high risk of cardiovascular events are long-term and independent of diabetes status, indicating that they have the potential to be beneficial for patients who do not currently meet the prescription criteria, says Dr Simon Cork, senior lecturer in physiology at Anglia Ruskin University

Glucagon is also found to affect brown fat in animal models, inducing thermogenesis and energy expenditure

In fact, research has shown that women with overweight or obesity who participated in weight loss programs were more likely to become pregnant than those who did not undertake weight loss interventions

Evaluation of phentermine and topiramate versus phentermine/topiramate extended-release in obese adults

doi: 10.1111/obr.13370

Middle East and Africa : Untapped Potential in Healthcare The Middle East and Africa (MEA) region is gradually emerging in the market, holding around 5% of the global share